Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Electron. j. biotechnol ; 53: 54-60, Sep.2021. ilus, tab, graf
Article in English | LILACS | ID: biblio-1451272

ABSTRACT

BACKGROUND Cancer is a life-threatening disease that affects approximately 18 million individuals worldwide. Breast cancer is the most common female neoplasm globally with more than 276,480 new cases of invasive breast cancer expected to be diagnosed in women in the U.S. alone in 2020. Genetic and epigenetic factors play role in the carcinogenesis and progression of this disease. In this study, MCF-7 adenocarcinoma cells were transfected with CRISPR/Cas9 plasmid to either knock out CDK11 or to activate CDH1. Treated cells were allografted into the mammary glands of female rats (150­190 g, 6­8 weeks) to evaluate the capability of these cells to control cancer progression and metastasis. RESULTS qPCR data revealed a significant downregulation of CDK11 and upregulation of CDH1. Cell cycle analysis and apoptosis assays indicated the knockout of CDK11 and simultaneous activation of CDH1 resulted in cell cycle arrest at G2/M phase and accumulation of cells at G2. Meanwhile, the percentage of cells that underwent late apoptosis increased in both genome editing hits. Histopathological sectioning data indicated that untransfected MCF-7 cells were capable of developing tumors in the mammary gland and initiation g angiogenesis. Transfected cells significantly restricted cancer cell infiltration/invasion by minimally localizing tumors and inhibiting angiogenesis. CONCLUSIONS Although further investigation is needed, the present data indicate the potentiality of using CRISPR/Cas9-based therapy as a promising approach to treat breast cancer. Impact: these data indicate targeting cancer-related genes via any genome editing tool might represent a novel approach to combat cancer.


Subject(s)
Animals , Female , Rats , Breast Neoplasms/genetics , Adenocarcinoma/genetics , Cdh1 Proteins/genetics , CRISPR-Associated Protein 9/genetics , Breast Neoplasms/secondary , Rats, Sprague-Dawley
2.
Acta Academiae Medicinae Sinicae ; (6): 205-209, 2016.
Article in Chinese | WPRIM | ID: wpr-289880

ABSTRACT

<p><b>OBJECTIVE</b>To study on the expression patterns of proteins associated with cell junctions in the developing mouse testes.</p><p><b>METHOD</b>The expression levels of reproductive related cell lines spermatogonia cell line GC1 spg, spermatocyte cell line GC2 spg, leydig cell line TM3, and sertoli cell line TM4, primary sertoli cells, and 1-6-week mouse testes were analyzed using Western blot.</p><p><b>RESULTS</b>The sertoli cell junction-associated membrane proteins adhesion molecule A, Occludin and Claudin, and the sertoli-germ cell junction-associated membrane proteins junctional adhesion molecule C, Nectin-3, and E-cadherin were stage-specific in the seminiferous tubules in the mouse testes. The adaptor proteins associated with cell juctions zonula occludens-1, zonula occludens-2, Afadin, Β-catenin, and CD2-associated protein were not stage-specific in the seminiferous tubules in the mouse testes.</p><p><b>CONCLUSIONS</b>In the seminiferous tubules in the mouse testes, the membrane proteins associated with cell junctions are stage-specific. However, the expressions of adaptor proteins associated with cell junctions do not obviously change.</p>


Subject(s)
Animals , Humans , Male , Mice , Adaptor Proteins, Signal Transducing , Metabolism , Cdh1 Proteins , Metabolism , Cell Adhesion Molecules , Metabolism , Cell Line , Cytoskeletal Proteins , Metabolism , Intercellular Junctions , Metabolism , Membrane Proteins , Metabolism , Microfilament Proteins , Metabolism , Nectins , Seminiferous Tubules , Cell Biology , Metabolism , Sertoli Cells , Cell Biology , Testis , Cell Biology , Zonula Occludens-1 Protein , Metabolism , Zonula Occludens-2 Protein , Metabolism , beta Catenin , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL